By Philipp A. Greif, Ludwig-Maximilians-Universität (LMU) Munich
Recent advances in DNA sequencing technology allow, for the first time, identification of tumor-specific gene mutations for each tumor at a genome-wide level. Most such mutations are acquired accidentally during lifetime, for example, during cell division or from exposure to environmental factors. If a cell acquires too many mutations in genes that are critical for growth and/or differentiation, the cell will be transformed into a malignant or cancer cell. If this happens to a blood-forming cell in bone marrow, the result is leukaemia. There is increasing evidence that, although cancers may look identical to a pathologist, they are highly diverse genetically and each cancer cell is, therefore, a “malignant individual”.